These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


206 related items for PubMed ID: 9680363

  • 1. Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases.
    Gu B, Bendall LJ, Wiley JS.
    Blood; 1998 Aug 01; 92(3):946-51. PubMed ID: 9680363
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Activation of the P2X7 receptor induces the rapid shedding of CD23 from human and murine B cells.
    Pupovac A, Geraghty NJ, Watson D, Sluyter R.
    Immunol Cell Biol; 2015 Jan 01; 93(1):77-85. PubMed ID: 25155463
    [Abstract] [Full Text] [Related]

  • 4. Transendothelial migration of lymphocytes in chronic lymphocytic leukaemia is impaired and involved down-regulation of both L-selectin and CD23.
    Chen JR, Gu BJ, Dao LP, Bradley CJ, Mulligan SP, Wiley JS.
    Br J Haematol; 1999 Apr 01; 105(1):181-9. PubMed ID: 10233382
    [Abstract] [Full Text] [Related]

  • 5. The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes.
    Gargett CE, Wiley JS.
    Br J Pharmacol; 1997 Apr 01; 120(8):1483-90. PubMed ID: 9113369
    [Abstract] [Full Text] [Related]

  • 6. Extracellular adenosine 5'-triphosphate induces a loss of CD23 from human dendritic cells via activation of P2X7 receptors.
    Sluyter R, Wiley JS.
    Int Immunol; 2002 Dec 01; 14(12):1415-21. PubMed ID: 12456589
    [Abstract] [Full Text] [Related]

  • 7. Partial agonists and antagonists reveal a second permeability state of human lymphocyte P2Z/P2X7 channel.
    Wiley JS, Gargett CE, Zhang W, Snook MB, Jamieson GP.
    Am J Physiol; 1998 Nov 01; 275(5):C1224-31. PubMed ID: 9814970
    [Abstract] [Full Text] [Related]

  • 8. ATP, a partial agonist for the P2Z receptor of human lymphocytes.
    Gargett CE, Cornish JE, Wiley JS.
    Br J Pharmacol; 1997 Nov 01; 122(5):911-7. PubMed ID: 9384508
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. P2X7 receptor activation induces cell death and CD23 shedding in human RPMI 8226 multiple myeloma cells.
    Farrell AW, Gadeock S, Pupovac A, Wang B, Jalilian I, Ranson M, Sluyter R.
    Biochim Biophys Acta; 2010 Nov 01; 1800(11):1173-82. PubMed ID: 20647033
    [Abstract] [Full Text] [Related]

  • 11. Chelerythrine and other benzophenanthridine alkaloids block the human P2X7 receptor.
    Shemon AN, Sluyter R, Conigrave AD, Wiley JS.
    Br J Pharmacol; 2004 Jul 01; 142(6):1015-9. PubMed ID: 15210579
    [Abstract] [Full Text] [Related]

  • 12. Pathways controlling the expression of surface CD21 (CR2) and CD23 (Fc(epsilon)IIR) proteins in human malignant B cells.
    Shubinsky G, Schlesinger M, Polliack A, Rabinowitz R.
    Leuk Lymphoma; 1997 May 01; 25(5-6):521-30. PubMed ID: 9250823
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. P2Z purinoceptor, a special receptor for apoptosis induced by ATP in human leukemic lymphocytes.
    Peng L, Bradley CJ, Wiley JS.
    Chin Med J (Engl); 1999 Apr 01; 112(4):356-62. PubMed ID: 11593539
    [Abstract] [Full Text] [Related]

  • 17. Transduction mechanisms of P2Z purinoceptors.
    Wiley JS, Chen JR, Snook MS, Gargett CE, Jamieson GP.
    Ciba Found Symp; 1996 Apr 01; 198():149-60; discussion 160-5. PubMed ID: 8879824
    [Abstract] [Full Text] [Related]

  • 18. Induction of the P2z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-gamma in the human THP-1 monocytic cell line.
    Humphreys BD, Dubyak GR.
    J Immunol; 1996 Dec 15; 157(12):5627-37. PubMed ID: 8955215
    [Abstract] [Full Text] [Related]

  • 19. Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages.
    Hu Y, Fisette PL, Denlinger LC, Guadarrama AG, Sommer JA, Proctor RA, Bertics PJ.
    J Biol Chem; 1998 Oct 16; 273(42):27170-5. PubMed ID: 9765236
    [Abstract] [Full Text] [Related]

  • 20. [Study on apoptosis of leukemic lymphocytes mediated by purinergic P2z receptors].
    Peng L, Bradley CJ, Wiley JS.
    Zhonghua Xue Ye Xue Za Zhi; 1998 Aug 16; 19(8):398-401. PubMed ID: 11189504
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.